Periodic monitoring Active

Key facts

  • Primary care consultations for respiratory illness remain at baseline levels across most EU/EEA countries, with one country reporting low activity. However, recent increases are observed in SARS-CoV-2 and influenza virus circulation.
  • SARS-CoV-2 activity remains low overall but continues to increase in primary and secondary care in several countries. The numbers of hospital admissions remain low, with most detections in secondary care reported among adults over 65 years of age.
  • Influenza virus activity remains low overall, with signs of increasing circulation in some countries, although detection numbers remain low and mainly driven by a small number of reporting countries. Hospitalisations remain low and have not increased further following slight increases observed in recent weeks in a few countries. Most detections are influenza A viruses, and hospitalised cases are predominantly among adults aged 65 years and older.
  • Respiratory syncytial virus (RSV) activity is low and at expected inter-seasonal levels.

Overview

ECDC monitors respiratory illness rates and virus activity across the EU/EEA. Findings are presented in the European Respiratory Virus Surveillance Summary (ERVISS.org), which is updated weekly.

Key visualisation from the weekly bulletin are included below.

All data are provisional and may be affected by reporting delays, incomplete country data or low testing volumes. A few countries with high testing rates can disproportionately influence pooled data. Further information is available under ‘Country notes’ and ‘Additional resources’.

Visualisations

Figure 1. ILI/ARI virological surveillance in primary care - weekly test positivity

Figure 2. SARI virological surveillance in hospitals - weekly test positivity

Figure 3. Key indicators

Figure 4. ILI/ARI virological surveillance in primary care - pathogen type and subtype distribution

Figure 5. SARI virological surveillance in hospitals - pathogen type and subtype distribution

Figure 6. Genetically characterised influenza virus distribution, week 40, 2025 – week 35, 2026

Figure 7. SARS-CoV-2 variant distribution, week 33, 2026 - week 34, 2026

Latest updates for this event

View all